€
M. Konig et al. / Tetrahedron 67 (2011) 4243e4252
4251
(CHCl3) lmax¼430, 544, 592 nm. The product is very unstable, and
both, in solid and solution, partial decomposition and reduction to
the corresponding Cu(II) species is observed.
4.6.11. Compound 7k: Cu 10-(4-aminophenyl-)5,15-bispentafluorop-
henylcorrole. Eluent DCM/hexanes 10:1. 10 mg (23% yield). 1H NMR
(500 MHz, CD2Cl2, 25 ꢀC):
d
¼7.97 (s, 2H, Hb), 7.64 (d, J(H,H)¼8 Hz,
2H, Ho), 7.59 (d, J(H,H)¼8 Hz, 2H, Hm), 7.49 (d, J(H,H)¼8 Hz, 2H, Ho),
7.43 (d, J(H,H)¼4 Hz, 2H, Hb), 7.31 (d, J(H,H)¼4 Hz, 2H, Hb), 7.23 (d,
J(H,H)¼4 Hz, 2H, Hb), 6.76 (d, J(H,H)¼8 Hz, 2H, Hm), 3.83 ppm (s, H,
4.6.7. Compound 7g: Cu 10-(4-(1-phenylsulfonylindole-3-yl-)phenyl-)
5,15-bispentafluorophenylcorrole. Eluent hexanes/DCM 2:1. A sec-
ond column chromatography was necessary (silica, hexanes/DCM
NH2); 13C NMR (125.8 MHz, CD2Cl2, 25 ꢀC):
d¼132.8 (CH), 131.3
1:1). 37 mg (72% yield). 1H NMR (500 MHz, CD2Cl2, 10 ꢀC):
d¼8.10
(CH), 130.2 (CH), 128.1 (CH), 126.7 (CH), 126.1 (CH), 123.2 (CH), 115.4
19
(d, J(H,H)¼8.2 Hz, 1H, indolyl-H7), 8.02 (br s, 2H, Hb), 7.98 (d,
J(H,H)¼7.5 Hz, 2H, phen-sulfonyl Ho), 7,91 (m(overlapping), 1H,
indolyl H4), 7.89 (d(overlapping), 2H, phenyl Hm), 7,86 (s(over-
lapping), 1H, indolyl H2), 7.77 (d, J(H,H)¼7.9 Hz, 2H, phenyl Hm),
7.70 (d, J(H,H)¼7.9 Hz, 2H, phenyl Ho) 7.57e7.62 (m, 1H, phen-
sulfonyl Hp), 7.45 (br s (overlapping), 2H, Hb), 7.40e7.43 (m, 1H,
indolyl H5), 7.33e7.37 (m, 1H, indolyl H6), 7.33 (br s, 2H, Hb), 7.28
(CH); F NMR (564.7 MHz, CD2Cl2, 30 ꢀC):
d
¼ꢁ138.04 (d, 3J(F,F)¼
17 Hz, 4F, Fo), ꢁ153.39 (t, 3J(F,F)¼19 Hz, 2F, Fp), ꢁ161.80 ppm (t,
3J(F,F)¼19 Hz, 4F, Fm); MS (ESIþ): m/z: calcd for C43H18CuF10N5:
857.07; found: 858.07 [MþH]þ; MS (ESIꢁ): m/z: calcd for
C43H20CuF10N7: 857.07; found: 857.47 [M]ꢁ; UV/vis (CH2Cl2)
lmax¼404, 552, 616 nm.
(br s, 2H, Hb); 13C NMR (125.8 MHz, CD2Cl2, 10 ꢀC):
d
¼132.9 (CH,
4.6.12. Compound 7l: Cu 10-(4-(4-benzo[b]thiophen-2-yl-)phenyl-)
5,15-bispentafluorophenylcorrole. Eluent hexanes/DCM 2:1. 20 mg
2C, Cb), 131.2 (CH, 2C, phenyl Co), 130.1 (CH, 1C, phen-sulfonyl Cp),
130.8 (CH, 2C, Cb), 129.9 (CH, 2C, Cb), 128.1 (CH, 2C, phenyl Cm),
127.5 (CH, 2C, phen-sulfonyl Co), 127.5 (CH, 2C, phen-sulfonyl Cm),
125.7 (CH, 1C, indolyl C5), 124.5 (CH, 1C, indolyl C6), 123.9 (CH, 2C,
Cb), 123.9 (CH, 1C, indolyl C2), 121.0 (CH, 1C, indolyl C4), 114.4 (CH,
(45% yield). 1H NMR (500 MHz, CD2Cl2, 10 ꢀC):
d
¼8.03 (2H, Hb), 7.88
(2H, Hm), 7.88 (2H, Hb), 7.67 (2H, Ho), 7.72 (s, 1H, Benzothienyl-H3),
7.71 (d, 1H, Benzothienyl-H7), 7.59 (d, J¼7.20 Hz, 1H, Benzothienyl-
H4), 7.34e7.41 (m, 1H, Benzothienyl-H6), 7.33 (2H, Hb), 7.28 (2H,
Hb), 7.13e7.18 (m, 1H, Benzothienyl-H5). 13C NMR (125.8 MHz,
1C, indolyl-C7); 19F NMR (282.4 MHz, CD2Cl2, 25 ꢀC):
d¼ꢁ138.02
(dd, 3J(F,F)¼21 Hz), ꢁ153.38 (t, 3J(F,F)¼21 Hz, 2F, Fp), ꢁ161.74 ppm
(dt, 3J(F,F)¼21 Hz, 4J(F,F)¼7.5 Hz, 4F, Fm); MS (ESIꢁ): m/z: calcd for
C51H21CuF10N5O2S: 1021.06; found: 1021.25 [M]ꢁ, 880.23
[Mꢁphenylsulfonyl]ꢁ; UV/vis (CH2Cl2) lmax¼401, 430(sh), 5550,
610 nm.
CD2Cl2, 25 ꢀC):
d
¼131.7 (CH),130.6 (CH),129.3 (CH),128.4 (CH),125.2
(CH), 124.0 (CH), 123.9 (CH), 122.2 (CH), 121.8 (CH), 119.5 (CH), 119.3
(CH); 19F NMR (282.4 MHz, CD2Cl2, 25 ꢀC):
d
¼ꢁ138.07 (br d, 3J(F,F)¼
20 Hz, 4F, Fo), ꢁ153.39 (t, 3J(F,F)¼20 Hz, 2F, Fp), ꢁ161.77 ppm (m, 4F,
Fm); MS (MALDIþ): m/z: calcd for C45H17CuF10N4S: 898.03; found:
898.07 [M]þ; UV/vis (CH2Cl2) lmax¼402, 431(sh), 547, 606 nm.
4.6.8. Compound 7h: Cu 10-(4-(benzo[b]furan-2-yl-)phenyl-)5,15-
bispentafluorophenylcorrole. Eluent hexanes/DCM 1:1. 36 mg (82%
4.7. DFT-calculations
yield). 1H NMR (500 MHz, CD2Cl2, 25 ꢀC):
d¼8.00 (br s, 2H, Hb), 7.71
(d, J(H,H)¼8.0 Hz, 2H, Hm), 7,65 (d, J(H,H)¼7.7 Hz,1H, Benzofuranyl-
H4), 7.57 (d, J(H,H)¼7.8 Hz, 1H, Benzofuranyl-H7), 7.48 (d(over-
lapping), 2H, Hb), 7.45 (m, 1H, Benzofuranyl-H5), 7.36e7.32 (m, 1H,
Benzofuranyl-H6), 7.33 (m(overlapping), 2H, Hb), 7.27 (m(over-
lapping), 2H, Ho), 7.26 (m(overlapping), 2H, Hb), 7.21 (s, 1H,
Benzofuranyl-H3); 13C NMR (125.8 MHz, CD2Cl2, 25 ꢀC): 131.3 (CH,
2C, Cb), 130.3 (CH, 2C, Cm), 129.5 (CH, 2C, Cb), 125.2 (CH, 2C, Cb),
125.0 (CH, 1C, Benzofuranyl-C5), 124.1 (CH, 1C, Benzofuranyl-C6),
123.2 (CH, 2C, Cb), 122.5 (CH, 2C, Co), 120.4 (CH, 1C, Benzofuranyl-
Calculationswereperformedbyusing the Gaussian 03package of
programs.41 The electronic structure calculations were based on the
Kohn-Sham density functional theory (KS-DFT) with Becke’s three-
parameter hybrid functional (B3LYP) and at DFT/mPW1PW91le-
vel.42,43 Relativistic electronic core potentials (ECPs)44 were used to
describe the electrons of Cu atoms. The basis set of Peterson and
Puzzarini45 was augmented by adding one set of polarization func-
tions on all atoms and one set of diffuse functions on all non-
hydrogen atoms. For C and H atoms all-electron split-valence 6-
311þG(d,p) basis sets supplemented with a single set of diffuse
functions on carbon atoms were employed. The vertical singlet
electronic states were studied using the extended Koopman’s the-
orem with time-dependent PBE0 density functional method (TD-
PBE0/BS-II).46 Energies and dipole moments reported herein were
evaluated using the second- and fourth-order Moeller-Plesset per-
turbation theory [MP2(full)/BS-II or MP4(SDQ)/BS-II] in combina-
tion with PBE0 parametrization [PBE0/BS-I].
C4), 110.5 (CH, 1C, Benzofuranyl-C7), 101.5 (CH, 1C, Benzofuranyl-
19
C3); F NMR (282.4 MHz, CD2Cl2, 25 ꢀC):
d
¼ꢁ138.08 (dd, 3J(F,F)¼
21 Hz, 4J(F,F)¼7.8 Hz, 4F, Fo), ꢁ153.40 (t, 3J(F,F)¼21 Hz, 2F, Fp),
ꢁ161.76 ppm (dt, 3J(F,F)¼21 Hz, 4J(F,F)¼7.8 Hz, 4F, Fm); MS (ESIꢁ):
m/z: calcd for C45H17CuF10N4O: 882.05; found: 882.27 [M]ꢁ; UV/vis
(CH2Cl2) lmax¼403, 431(sh), 546, 601 nm;
4.6.9. Compound 7i: Cu 10-(4-(m-nitro-phenyl)phenyl-)5,15-bis-
pentafluorophenylcorrole. Eluent hexanes/DCM 2:1. 35 mg (79%
yield). 1H NMR (500 MHz, CD2Cl2, 10 ꢀC):
d
¼8.51 (s, 1H, nitrophen-
4.8. Crystal structure determination
H20), 8.29 (d, J(H,H)¼8.3 Hz,1H, nitrophen-H40), 8.22 (br m, 2H, Hb),
8.00 (J(H,H)¼8.2 Hz, 1H, nitrophen-H60), 7.78e7.84 (m, 1H, nitro-
phenn-H50), 7.72 (d, J(H,H)¼7.5 Hz, 2H, Hm), 7.49 (br s, 2H, Hb), 7.40
(m, 2H, Ho), 7.23 (br s, 2H, Hb), 7.29 (br s, 2H, Hb); 13C NMR
Crystalsof 5and7aweremountedonaMitegenMicromountwere
automatically centred on a Bruker SMART X2S benchtop crystallo-
graphic system. Intensity measurements were performed using
(125.8 MHz, CD2Cl2, 25 ꢀC):
d
¼133.4 (CH), 130.6 (CH), 129.5 (CH),
monochromated (doubly curved silicon crystal) Mo Ka-radiation
ꢀ
126.2 (CH), 124.5 (CH), 122.4 (CH), 122.0 (CH), 121.3 (CH), 118.5 (CH),
(0.71073 A) from a sealed microfocus tube. APEX2 software was used
for preliminary determination of the unit cell.47 Determinations of
integrated intensities and unit cell refinement were performed using
SAINT.48 Data were corrected for absorption effects with SADABS
using the multi-scan technique.49 The structures were solved by di-
rect methods (SHELXS-97)51 and refined by full-matrix least-squares
on Fo2 (SHELXL-97).50,51 The H atoms were calculated geometrically,
and a riding model was applied during the refinement process.
The cell parameters of 7a suggest a monoclinic space group, but
the tolyl substituent could not be resolved in P21/c. Structure so-
lution in the triclinic space group Pꢁ1 reveals a disorder of the tolyl
19
118.2 (CH); F NMR (282.4 MHz, CD2Cl2, 25 ꢀC):
d¼ꢁ138.08 (br d,
3J(F,F)¼22 Hz, 4F, Fo), ꢁ153.36 (t, 3J(F,F)¼22 Hz, 2F, Fp), ꢁ161.79 ppm
(bt, 3J(F,F)¼22 Hz, 4F, Fm); MS (MALDIþ): m/z: calcd for
C43H16CuF10N5O2: 887.04; found: 887.22 [M]þ; UV/vis (CH2Cl2)
lmax¼403, 422(sh), 547, 604 nm;
4.6.10. Compound 7j: Cu 10-(4-(2,4,6-tri(isopropyl)-phenyl)phenyl-)
5,15-bispentafluorophenylcorrole. Only traces of the reaction prod-
uct were observed in the reaction mixture: MS (MALDIþ): m/z:
calcd for C52H35CuF10N4: 968.20; found: 968.41 [M]þ;